Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.

Gordon T Bolger; Albert Licollari; Amin Tan; Richard Greil; Brigitta Vcelar; Sigrun Greil-Ressler; Lukas Weiss; Charlotte Schönlieb; Teresa Magnes; Bianca Radl; Muhammed Majeed; Peter P Sordillo

doi:10.1007/s00280-018-3730-5

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.

Gordon T Bolger, Albert Licollari, Amin Tan, Richard Greil (Co-author), Brigitta Vcelar, Sigrun Greil-Ressler (Co-author), Lukas Weiss (Co-author), Charlotte Schönlieb (Co-author), Teresa Magnes (Co-author), Bianca Radl (Co-author), Muhammed Majeed, Peter P Sordillo

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article (Journal) › peer-review

20 Citations (Web of Science)

Original language	English
Pages (from-to)	265-275
Journal	CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume	83
Issue number	2
DOIs	https://doi.org/10.1007/s00280-018-3730-5
Publication status	Published - 2019

Keywords

ERYTHROCYTE SODIUM
BLOOD
METABOLITES
PHASE
CELLS
TETRAHYDROCURCUMIN
ABSORPTION
THERAPY
KINASE
TISSUE

Access to Document

10.1007/s00280-018-3730-5

Cite this

Bolger, G. T., Licollari, A., Tan, A., Greil, R., Vcelar, B., Greil-Ressler, S., Weiss, L., Schönlieb, C., Magnes, T., Radl, B., Majeed, M., & Sordillo, P. P. (2019). Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 83(2), 265-275. https://doi.org/10.1007/s00280-018-3730-5

Bolger, Gordon T ; Licollari, Albert ; Tan, Amin et al. / Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals. In: CANCER CHEMOTHERAPY AND PHARMACOLOGY 2019 ; Vol. 83, No. 2. pp. 265-275.

@article{0cd26f53adb94ee5946eb55813159131,

title = "Pharmacokinetics of liposomal curcumin (Lipocurc{\texttrademark}) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.",

keywords = "ERYTHROCYTE SODIUM, BLOOD, METABOLITES, PHASE, CELLS, TETRAHYDROCURCUMIN, ABSORPTION, THERAPY, KINASE, TISSUE",

author = "Bolger, {Gordon T} and Albert Licollari and Amin Tan and Richard Greil and Brigitta Vcelar and Sigrun Greil-Ressler and Lukas Weiss and Charlotte Sch{\"o}nlieb and Teresa Magnes and Bianca Radl and Muhammed Majeed and Sordillo, {Peter P}",

note = "Greil, Greil‑Ressler, Weiss, Sch{\"o}nlieb, Magnes, Radl: III rd Medical Department, Paracelsus Medical University Salzburg, Salzburg, Austria & Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT), Salzburg, Austria; Greil: Cancer Cluster Salzburg, Salzburg, Austria",

year = "2019",

doi = "10.1007/s00280-018-3730-5",

language = "English",

volume = "83",

pages = "265--275",

journal = "CANCER CHEMOTHERAPY AND PHARMACOLOGY ",

issn = "0344-5704",

number = "2",

}

Bolger, GT, Licollari, A, Tan, A, Greil, R, Vcelar, B, Greil-Ressler, S , Weiss, L, Schönlieb, C, Magnes, T , Radl, B, Majeed, M & Sordillo, PP 2019, 'Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.', CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol. 83, no. 2, pp. 265-275. https://doi.org/10.1007/s00280-018-3730-5

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals. / Bolger, Gordon T; Licollari, Albert; Tan, Amin et al.
In: CANCER CHEMOTHERAPY AND PHARMACOLOGY , Vol. 83, No. 2, 2019, p. 265-275.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.

AU - Bolger, Gordon T

AU - Licollari, Albert

AU - Tan, Amin

AU - Greil, Richard

AU - Vcelar, Brigitta

AU - Greil-Ressler, Sigrun

AU - Weiss, Lukas

AU - Schönlieb, Charlotte

AU - Magnes, Teresa

AU - Radl, Bianca

AU - Majeed, Muhammed

AU - Sordillo, Peter P

N1 - Greil, Greil‑Ressler, Weiss, Schönlieb, Magnes, Radl: III rd Medical Department, Paracelsus Medical University Salzburg, Salzburg, Austria & Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT), Salzburg, Austria; Greil: Cancer Cluster Salzburg, Salzburg, Austria

PY - 2019

Y1 - 2019

KW - ERYTHROCYTE SODIUM

KW - BLOOD

KW - METABOLITES

KW - PHASE

KW - CELLS

KW - TETRAHYDROCURCUMIN

KW - ABSORPTION

KW - THERAPY

KW - KINASE

KW - TISSUE

U2 - 10.1007/s00280-018-3730-5

DO - 10.1007/s00280-018-3730-5

M3 - Original Article (Journal)

C2 - 30430227

SN - 0344-5704

VL - 83

SP - 265

EP - 275

JO - CANCER CHEMOTHERAPY AND PHARMACOLOGY

JF - CANCER CHEMOTHERAPY AND PHARMACOLOGY

IS - 2

ER -

Bolger GT, Licollari A, Tan A, Greil R, Vcelar B, Greil-Ressler S et al. Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals. CANCER CHEMOTHERAPY AND PHARMACOLOGY . 2019;83(2):265-275. doi: 10.1007/s00280-018-3730-5